Astral VAPS AutoEPAP Clinical Trial
Completed · Phase 3
Conditions studied: Upper Airway Obstruction, Respiratory Insufficiency, Respiratory Failure
In brief
Patients with chronic respiratory failure such as those associated with Chronic Obstructive Pulmonary Disease (COPD), Obesity Hypoventilation Syndrome (OHS), Obstructive Sleep Apnea (OSA) or Neuromuscular Disease (NMD) are increasingly managed with domiciliary non-invasive positive pressure ventilation (NIPPV). The aim of this study is to now compare the Automatic Expiratory Positive Airway Pressure (AutoEPAP) algorithm with a fixed manual EPAP in iVAPS mode on an Astral mixed mode ventilator. It is proposed that the automatic settings of AutoEPAP will be as effective at managing respiratory failure and upper airway obstruction (UAO) as manual EPAP on the Astral device. Specifically demonstrating that the AutoEPAP function is as effective at treating UAO as manual EPAP.
Key facts
- Study ID
- NCT02683772
- Run by
- ResMed
- People needed
- 42
- Starts
- 2016-04-15
- Expected to finish
- 2017-07-06
- Last updated by the study team
- 2019-07-26
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of California, San Diego — La Jolla, California, United States
- National Jewish Health — Denver, Colorado, United States
- Lisa F. Wolfe, MD — Chicago, Illinois, United States
- Temple University — Philadelphia, Pennsylvania, United States
- University of Utah — Salt Lake City, Utah, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.